Download
Download by
Scanning QR Code
  • Download app

    Download app

  • Online Inquiry

    Log in to access Online Inquiry
+
Congratulations
You've successfully got advanced quotes worth 5000 HKD
Download APP >>
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
Futubull > Quotes > XLO Xilio Therapeutics > Detailed Quotes

XLO Xilio Therapeutics

Watchlist
2.520
+0.050+2.02%
Close 08/11 16:00 ET
2.52000.00%
Post Mkt Price 08/11 16:00 ET
Giving away premium quotes worth 5000 HKD/year to unlock more data
Get NOW
High
2.770
Open
2.380
Turnover
504.77K
Low
2.370
Pre Close
2.470
Volume
196.79K
Market Cap
69.23M
P/E(TTM)
Loss
52wk High
27.950
Shares
27.47M
P/E(Static)
Loss
52wk Low
2.040
Float Cap
22.73M
Bid/Ask %
91.30%
Historical High
27.950
Shs Float
9.02M
Volume Ratio
1.67
Historical Low
2.040
Dividend TTM
--
Div Yield TTM
--
P/B
0.48
Dividend LFY
--
Div Yield LFY
--
Turnover Ratio
2.18%
Amplitude
16.19%
Avg Price
2.565
Lot Size
1
Float Cap
22.73M
Bid/Ask %
91.30%
Historical High
27.950
Shs Float
9.02M
Volume Ratio
1.67
Historical Low
2.040
Dividend TTM
--
P/B
0.48
Dividend LFY
--
Turnover Ratio
2.18%
Amplitude
16.19%
Avg Price
2.565
Lot Size
1
Price Forecast

No Data

News

Comment

Company Overview More
Xilio Therapeutics, Inc., a clinical-stage biotechnology company, develops immunotherapies to improve the immune system of cancer patients. Its checkpoint inhibitor program includes XTX101, a clinical-stage, tumor-selective anti-CTLA-4 mAb that is in Phase 1/2 clinical trials in patients with solid tumors. The company also develops cytokine programs, which comprises XTX202, a modified form of IL-2; XTX301, an IL-12 product candidate; and XTX401, an IL-15 product candidate that are masked with a protein domain to prevent binding activity until cleaved off by tumor microenvironment (TME)-associated proteases. Xilio Therapeutics, Inc. was founded in 2016 and is headquartered in Waltham, Massachusetts.
CEO: Russo BCPS, Pharm.D, Pharm.D., Rene
Market: NASDAQ
Futu Hot List
USHKCN
TradeSearchNews
SymbolLatest price%Chg

Loading...

Watchlist
Back to the Top